184 related articles for article (PubMed ID: 36986797)
1. Development and Characterization of Quercetin-Loaded Delivery Systems for Increasing Its Bioavailability in Cervical Cancer Cells.
Ferreira M; Gomes D; Neto M; Passarinha LA; Costa D; Sousa Â
Pharmaceutics; 2023 Mar; 15(3):. PubMed ID: 36986797
[TBL] [Abstract][Full Text] [Related]
2. Preparation and Biophysical Characterization of Quercetin Inclusion Complexes with β-Cyclodextrin Derivatives to be Formulated as Possible Nose-to-Brain Quercetin Delivery Systems.
Manta K; Papakyriakopoulou P; Chountoulesi M; Diamantis DA; Spaneas D; Vakali V; Naziris N; Chatziathanasiadou MV; Andreadelis I; Moschovou K; Athanasiadou I; Dallas P; Rekkas DM; Demetzos C; Colombo G; Banella S; Javornik U; Plavec J; Mavromoustakos T; Tzakos AG; Valsami G
Mol Pharm; 2020 Nov; 17(11):4241-4255. PubMed ID: 32986435
[TBL] [Abstract][Full Text] [Related]
3. Development of Chitosan/Cyclodextrin Nanospheres for Levofloxacin Ocular Delivery.
De Gaetano F; Marino A; Marchetta A; Bongiorno C; Zagami R; Cristiano MC; Paolino D; Pistarà V; Ventura CA
Pharmaceutics; 2021 Aug; 13(8):. PubMed ID: 34452254
[TBL] [Abstract][Full Text] [Related]
4. Thermosensitive
Gözcü S; Polat KH
Turk J Pharm Sci; 2023 May; 20(2):78-83. PubMed ID: 37161283
[TBL] [Abstract][Full Text] [Related]
5. Supramolecular Arrangement of Doxycycline with Sulfobutylether-β-Cyclodextrin: Impact on Nanostructuration with Chitosan, Drug Degradation and Antimicrobial Potency.
Carvalho Feitosa R; Souza Ribeiro Costa J; van Vliet Lima M; Sawa Akioka Ishikawa E; Cogo Müller K; Bonin Okasaki F; Sabadini E; Garnero C; Longhi MR; Lavayen V; da Silva-Júnior AA; Oliveira-Nascimento L
Pharmaceutics; 2023 Apr; 15(4):. PubMed ID: 37111770
[TBL] [Abstract][Full Text] [Related]
6. Design of Besifloxacin HCl-Loaded Nanostructured Lipid Carriers:
Polat HK; Kurt N; Aytekin E; Akdağ Çaylı Y; Bozdağ Pehlivan S; Çalış S
J Ocul Pharmacol Ther; 2022; 38(6):412-423. PubMed ID: 35675672
[No Abstract] [Full Text] [Related]
7. Drug-in-cyclodextrin-in-polymeric nanoparticles: A promising strategy for rifampicin administration.
Abruzzo A; Croatti V; Zuccheri G; Pasquale Nicoletta F; Sallustio V; Corazza E; Vitali B; Cerchiara T; Luppi B; Bigucci F
Eur J Pharm Biopharm; 2022 Nov; 180():190-200. PubMed ID: 36210035
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the Anti-Leukemic Potential of Thymoquinone/Sulfobutylether-β-cyclodextrin (SBE-β-CD) Inclusion Complexes.
Eid EEM; Alshehade SA; Almaiman AA; Kamran S; Lee VS; Alshawsh MA
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509531
[TBL] [Abstract][Full Text] [Related]
9. Physicochemical and structural characterization of quercetin-beta-cyclodextrin complexes.
Zheng Y; Haworth IS; Zuo Z; Chow MS; Chow AH
J Pharm Sci; 2005 May; 94(5):1079-89. PubMed ID: 15793810
[TBL] [Abstract][Full Text] [Related]
10. The preparation, characterization, and pharmacokinetic studies of chitosan nanoparticles loaded with paclitaxel/dimethyl-β-cyclodextrin inclusion complexes.
Ye YJ; Wang Y; Lou KY; Chen YZ; Chen R; Gao F
Int J Nanomedicine; 2015; 10():4309-19. PubMed ID: 26170666
[TBL] [Abstract][Full Text] [Related]
11. A New Insight to Silver Sulfadiazine Antibacterial Dressings: Nanoparticle-Loaded Nanofibers for Controlled Drug Delivery.
Mutlu-Ağardan NB; Tort S; Aydoğduoğlu Ş; Kıymacı ME
AAPS PharmSciTech; 2022 Nov; 24(1):8. PubMed ID: 36451066
[TBL] [Abstract][Full Text] [Related]
12. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
[TBL] [Abstract][Full Text] [Related]
13. Development of chitosan/halloysite/graphitic‑carbon nitride nanovehicle for targeted delivery of quercetin to enhance its limitation in cancer therapy: An in vitro cytotoxicity against MCF-7 cells.
Sabzini M; Pourmadadi M; Yazdian F; Khadiv-Parsi P; Rashedi H
Int J Biol Macromol; 2023 Jan; 226():159-171. PubMed ID: 36435458
[TBL] [Abstract][Full Text] [Related]
14. Quercetin, Rutin And Quercetin-Rutin Incorporated Hydroxypropyl β-Cyclodextrin Inclusion Complexes.
Başaran E; Öztürk AA; Şenel B; Demirel M; Sarica Ş
Eur J Pharm Sci; 2022 May; 172():106153. PubMed ID: 35227839
[TBL] [Abstract][Full Text] [Related]
15. Chloramphenicol/sulfobutyl ether-β-cyclodextrin complexes in an ophthalmic delivery system: prolonged residence time and enhanced bioavailability in the conjunctival sac.
Xu Y; Zhang C; Zhu X; Wang X; Wang H; Hu G; Fu Q; He Z
Expert Opin Drug Deliv; 2019 Jun; 16(6):657-666. PubMed ID: 31033370
[No Abstract] [Full Text] [Related]
16. Inclusion Complex of Docetaxel with Sulfobutyl Ether β-Cyclodextrin: Preparation, In Vitro Cytotoxicity and In Vivo Safety.
Ren L; Yang X; Guo W; Wang J; Chen G
Polymers (Basel); 2020 Oct; 12(10):. PubMed ID: 33066097
[TBL] [Abstract][Full Text] [Related]
17. Inclusion Complex of Isoliquiritigenin With Sulfobutyl Ether-β-Cyclodextrin: Preparation, Characterization, Inclusion Mode, Solubilization, and Stability.
Wu X; Li J; Hu C; Zheng Y; Zhang Y; Li J; Li M; Xiao D; Lu L; Huang Y; Zhang X; Li C
Front Chem; 2022; 10():930297. PubMed ID: 35800032
[TBL] [Abstract][Full Text] [Related]
18. Amphiphilic carboxymethyl chitosan-quercetin conjugate with P-gp inhibitory properties for oral delivery of paclitaxel.
Wang X; Chen Y; Dahmani FZ; Yin L; Zhou J; Yao J
Biomaterials; 2014 Aug; 35(26):7654-65. PubMed ID: 24927684
[TBL] [Abstract][Full Text] [Related]
19. Development and physicochemical characterization of chitosan hydrochloride/sulfobutyl ether-β-cyclodextrin nanoparticles for cinnamaldehyde entrapment.
Zhu W; Wu J; Guo X; Sun X; Li Q; Wang J; Chen L
J Food Biochem; 2020 Jun; 44(6):e13197. PubMed ID: 32189350
[TBL] [Abstract][Full Text] [Related]
20. Design and Evaluation of An Extended-Release Olmesartan Tablet Using Chitosan/Cyclodextrin Composites.
Anraku M; Tabuchi R; Goto M; Iohara D; Mizukai Y; Maezaki Y; Michihara A; Kadowaki D; Otagiri M; Hirayama F
Pharmaceutics; 2019 Feb; 11(2):. PubMed ID: 30781383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
